BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12492744)

  • 1. Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study.
    Hicken BL; Sharara AI; Abrams GA; Eloubeidi M; Fallon MB; Arguedas MR
    Aliment Pharmacol Ther; 2003 Jan; 17(1):145-53. PubMed ID: 12492744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding.
    Raines DL; Dupont AW; Arguedas MR
    Aliment Pharmacol Ther; 2004 Mar; 19(5):571-81. PubMed ID: 14987326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage.
    Vorobioff JD; Groszmann RJ
    Ann Hepatol; 2013; 12(1):22-9. PubMed ID: 23293190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
    Imperiale TF; Chalasani N; Klein RW
    Am J Gastroenterol; 2003 Dec; 98(12):2742-50. PubMed ID: 14687827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
    Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B
    Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!
    Merkel C; Montagnese S
    Eur J Intern Med; 2011 Feb; 22(1):1-4. PubMed ID: 21238883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
    Targownik LE; Spiegel BM; Dulai GS; Karsan HA; Gralnek IM
    Am J Gastroenterol; 2004 Jul; 99(7):1306-15. PubMed ID: 15233670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.
    Tey TT; Gogna A; Irani FG; Too CW; Lo HG; Tan BS; Tay KH; Lui HF; Chang PE
    Singapore Med J; 2016 Mar; 57(3):132-7. PubMed ID: 26996384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of portal pressure.
    Abraldes JG; Sarlieve P; Tandon P
    Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis.
    Le Moine O; Hadengue A; Moreau R; Sogni P; Soupison T; Yang S; Hartleb M; Lebrec D
    Scand J Gastroenterol; 1997 Jul; 32(7):731-5. PubMed ID: 9246716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prophylaxis of variceal bleeding in cirrhosis.
    Brett BT; Hayes PC; Jalan R
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):349-58. PubMed ID: 11338061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.